# Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation

> **NCT05233605** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 72 (estimated)

## Conditions studied

- Severe COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05233605
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-21
- **Primary completion:** 2026-02-04
- **Final completion:** 2026-02-04
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05233605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05233605, "Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05233605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*